Tag: DoD
-
H1N1 Drug Gets Positive Results in Preclinical Tests
AVI BioPharma Inc. of Bothell, Washington reported positive results from two preclinical studies evaluating the therapeutic potential of its drug AVI-7100 against a fully virulent pandemic H1N1 virus, also known as swine flu. The results showed statistically significant reductions in average viral titer — a quantitative measure of biological activity in a recombinant virus —…